Gyre Therapeutics (GYRE) Dividends Paid - Common (2023)

Gyre Therapeutics (GYRE) reported Dividends Paid - Common of $1.5 million for Q3 2023, down 57.14% quarter-over-quarter from $3.5 million in Q2 2023.

Gyre Therapeutics (GYRE) Dividends Paid - Common (2023) Analysis & Trends

Gyre Therapeutics (GYRE) has 1 years of Dividends Paid - Common data on file, last reported at $1.5 million in Q3 2023.

Dividends Paid - Common for Q3 2023 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $12.8 million (changed N/A YoY), and the FY2022 annual result was $45.0 million, changed N/A from the prior year.
Dividends Paid - Common declined to $1.5 million in Q3 2023 per GYRE's latest filing, from $3.5 million in the prior quarter.
Over five years, Dividends Paid - Common peaked at $7.8 million in Q1 2023 and troughed at $1.5 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Gyre Therapeutics	554.75 Mn	540.62 Mn	8.38 Mn	-

Download Data